BCP
AGN

Berkeley Capital Partners’s Allergan plc AGN Stock Holding History

Berkeley Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,701
Closed -$759K – 127
2017
Q3 		$759K Sell
3,701
-20
-0.5% -$4.65K 0.51% 50
2017
Q2 		$905K Buy
3,721
+10
+0.3% +$2.35K 0.62% 37
2017
Q1 		$887K Buy
+3,711
New +$864K 0.6% 38
2016
Q1 		– Sell
-743
Closed -$232K – 129
2015
Q4 		$232K Buy
+743
New +$221K 0.19% 97

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Berkeley Capital Partners's AGN Position: Q4 2017 in Review

Berkeley Capital Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 3,701 shares — an estimated $759K sold.

Berkeley Capital Partners first reported a position in AGN in Q4 2015 and held it in 4 quarters. The position peaked at $905K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Berkeley Capital Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Berkeley Capital Partners sold 3,701 Allergan plc shares in Q4 2017, an estimated $759K.
  • Berkeley Capital Partners first reported a position in Allergan plc in Q4 2015 and held it in 4 quarters.
  • Berkeley Capital Partners's Allergan plc position peaked at $905K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Berkeley Capital Partners's 13F filing for Q4 2017, filed 2 Feb 2018.